Tuesday, July 27, 2010

Investorideas.com - Biotech/ Pharma Stocks; OTCBB Most Active Trading News: OTC Volume Leaders; ($0.25-$0.50): (OTCBB: CHTL), (OTCBB: NPHC), (OTCBB: CAMH), (OTCBB: SNBP)

Investorideas.com - Biotech/ Pharma Stocks; OTCBB Most Active Trading News: OTC Volume Leaders; ($0.25-$0.50): (OTCBB: CHTL), (OTCBB: NPHC), (OTCBB: CAMH), (OTCBB: SNBP)


Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS
Category: Investment, Financial
Share this news:
var addthis_pub = 'investorideas';
Subscribe to Investor Ideas Newswire
Visit this company: www.otcvolumeleaders.com
Point Roberts, WA (Investorideas.com Newswire) July 27, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($0.25-$0.50) include China Tel Group Inc . (OTCBB: CHTL), Nutra Pharma Corporation (OTCBB: NPHC),Cambridge Heart Inc. (OTCBB: CAMH), and SINOBIOPHARMA, INC (OTCBB: SNBP).


Sign up for Free OTC Volume Leader Alerts!
http://bit.ly/otcvolumeleaders


OTC / Market Commentary:
Sectors include Biotech/ Pharma Stocks
One of the OTCBB volume leaders: SINOBIOPHARMA, INC (OTCBB: SNBP)"Sinobiopharma is a fully integrated and highly innovative specialty biopharmaceutical company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, one of the world's fastest growing pharmaceutical markets. Known as Dong Ying (Jiangsu) Pharmaceutical Co., Ltd. in China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs. Sinobiopharma has patented new methods for synthesizing active pharmaceutical ingredients (API) at a lower cost and owns drug delivery formulations that improve usability. For additional information, please visit the Company's website at: www.sinobp.com."


Market Snapshot: (at time of release)

Dow 10,550.03 +24.60 +0.23%
Nasdaq 2,291.97 -4.46 -0.19%
S&P 500 1,115.63 +0.62 +0.06%
10 Yr Bond(%) 3.0450% +0.5100
Oil 77.32 -1.66 -2.10%
Gold 1,162.80 -20.20 -1.71%


OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.


OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.

Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

No comments: